Sector: health
Conviction from: NASDAQS&P
52-week range: 43.2072.69
Bio-Techne supplies proteins, antibodies, reagents, and instruments for life-science research and molecular and cell-based diagnostics.
6 tracked filer(s) hold this · 3 opened, 1 added, 2 trimmed in 30-JUN-2026
Aggregate 13FScore 56 — mean of 6 scored holder(s) · buyers (new/add) avg 51. Higher = the smart money in this name has the better track record.
| Filer | 13FScore | This quarter | Shares | Value | % of their book |
|---|
| George Soros / Soros Fund Mgmt | 33 | New buy | 535,400 | $37,826,010 | 0.5% |
| Paul Tudor Jones / Tudor | 63 | New buy | 943,287 | $66,643,227 | 0.1% |
| Louis Bacon / Moore | 53 | New buy | 125,626 | $8,875,477 | 0.1% |
| Bridgewater | 56 | Added +348% | 26,750 | $1,889,888 | 0.0% |
| Ruane Cunniff / Sequoia Fund | 75 | Trimmed -1% | 3,348,841 | $236,595,617 | 3.7% |
| Larry Robbins / Glenview | 58 | Trimmed -69% | 58,324 | $4,120,591 | 0.1% |
Beyond 13F — activists, insiders, politicians & research
6 disclosed trade(s) by 1 filer(s).
| Trade date | Who | Type | Amount | |
|---|
| 2026-04-08 | April McClain Delaney MD06 | SELL | $1,001 - $15,000 | PTR |
| 2026-03-26 | April McClain Delaney MD06 | SELL | $1,001 - $15,000 | PTR |
| 2026-02-24 | April McClain Delaney MD06 | SELL | $1,001 - $15,000 | PTR |
| 2026-01-28 | April McClain Delaney MD06 | SELL | $1,001 - $15,000 | PTR |
| 2025-12-05 | April McClain Delaney MD06 | BUY | $1,001 - $15,000 | PTR |
| 2025-12-02 | April McClain Delaney MD06 | BUY | $1,001 - $15,000 | PTR |
2 disclosed trade(s) by 1 filer(s).
| Report | Date | Stance |
|---|
| #97 — Rough Seas Make Strong Sailors: Navigating the Healthcare Policy Tsunami | 2025-05-28 | WATCH |